Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Cart

No products in the cart.

Scientific Communications

New highlight in Annals of Oncology!
In this study, Peyraud at al. show that plasmatic level of L-Arginine (Arg) is associated with clinical outcome of patients treated with immune checkpoint blockers (ICB). Using an ELISA approach for Arg quantification (#IS-I-0400R) applied on two independent cohorts, authors demonstrated that low plasmatic level of Arg was associated with a worse clinical outcome.  

Read more

Among mechanisms associated with cancer immune evasion, the activation of the Kynurenine Pathway (KP) is known to play a key role and has thus been proposed as a therapeutic target to improve current immune checkpoint blockade-based immunotherapies.

Read more

Our Kynurenine/Tryptophan ELISA pack recently cited in Cancer Discovery in a publication written by Marta Galan-Diez et al. In this occasion, benefit from the spring sale on our Kynurenine / Tryptophan ELISA pack until April 30!

Read more

ImmuSmol products trusted by scientists and highlighted in recent publications!
Discover the recent studies where some of our top products have been used and have helped advance research.

Read more

Discover the scientific publications written in 2021 that cite Immusmol products! Antibodies, STAINperfect and ELISA kits were used and referenced in these recent articles that we have selected.
For more informations check out our product page!

Read more

We developed and validated a newSerine ELISA kit (#IS-I-1200) which allows for L-Ser quantitation in biological samples including plasma, sera as well as cell culture supernatants. The assay requires a low sample volume of 10μL and is characterized by a 2.4µM sensitivity.

Read more

Glutamine metabolism is an attractive therapeutic path in immuno-oncology. Glutamine level should rely mainly on Glutamine quantification, which can now be addressed by ELISA!

Read more

New therapeutic options in immuno-oncology consist in manipulating metabolic pathways. Whatever the mechanism of action of drug candidates Arginine remains a suitable surrogate biomarker of Arginase activity. Its quantification can be approached by ELISA!

Read more

We have set up and validated a series of antibodies targeting key neurotransmitters, including among others dopamine, serotonin, glutamate, noradrenaline. Besides antibodies, and for appropriate biological sample preparation, we developed an immunostaining kit that allows for immunofluorescence staining of various types of biological materials, as illustrated in these recent publications.

Read more

Our products were hilighted in 2020 in these scientific publication. Antibodies, STAINperfect and ELISA kits were used and referenced.

Read more

Novel therapeutic options in immuno-oncology consist in manipulating – directly or indirectly – metabolic pathways such as the one of IDO to relieve the immunosupressive functions of M2 macrophages. As to investigate innovative direct or indirect modulators of IDO activity, Kynurenine and Tryptophan represent valuable biomarkers to be measured and can easily be adressed through ELISA kits which thus offer screening capacities.

Read more

Arginine (ARG) is a basic non-essential amino acid well known to participate in physiological functions such as i) vascular tone homeostasis as contributing to the production of nitric oxide (NO) and ii) immune response control, through NO synthase (NOS) and Arginase enzymes, respectively. Our new validated IS-I-0400 ELISA kit allows for the determination of ARG in serum and plasma samples of a volume as low as 20μL and with a sensitivity of 2.1µM.

Read more

Contact
us